Nurix Therapeutics Alternatives & Competitors
12 companies similar to Nurix Therapeutics — Nurix is writing medicine’s next chapter using targeted protein degradation as a...
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
Cambridge, United States
insitro
insitro is the physical AI company built on causal biology. ┈➤ Find us on Substack: http...
South San Francisco, Unit...
Biopharmaceutical Research Company
Developing the Next Generation of Cannabinoid Therapeutics
United States
Solu Therapeutics
Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...
Boston, United States
Track all Nurix Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
MindMaze Therapeutics
Accelerating humanity’s ability to recover, learn and adapt through advanced neuroscience...
Lausanne, Switzerland
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
Agoura Hills, United Stat...
UCB
We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by s...
Brussels, Belgium
Jasper Therapeutics
Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat...
Redwood City, United Stat...
Noema Pharma
A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for C...
Basel, Switzerland
Montara Therapeutics, Inc.
At Montara, we’re developing safer, more efficacious therapies to improve the lives of pat...
San Francisco, United Sta...
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
About Nurix Therapeutics
Nurix is writing medicine’s next chapter using targeted protein degradation as a new script to outmatch disease.
Development of degrader-based therapeutics, Collaborative pharmaceutical development, Clinical trial management and execution, Drug discovery utilizing DEL-AI technology
Patients with oncology, immunology, and neurology conditions, Pharmaceutical industry partners, Healthcare professionals and researchers
Targeted Protein Degradation, Degrader-based Medicines, Ubiquitin-proteasome System, Therapeutics Development, Life Sciences, Disease Treatment Innovation, Protein Degradation Machinery, Pharmaceutical Research, Novel Therapeutics, Next-generation Medicine
B2B, Platform
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Nurix Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Nurix Therapeutics on 23 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 20 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.